HomeBLISSGVS • NSE
add
Bliss GVS Pharma Ltd
Previous close
₹163.84
Day range
₹160.00 - ₹165.99
Year range
₹92.15 - ₹172.42
Market cap
17.00B INR
Avg Volume
1.55M
P/E ratio
27.15
Dividend yield
0.31%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.18B | 2.74% |
Operating expense | 682.58M | 6.38% |
Net income | 242.60M | -42.66% |
Net profit margin | 11.14 | -44.22% |
Earnings per share | — | — |
EBITDA | 414.11M | -23.69% |
Effective tax rate | 28.04% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.20B | 34.93% |
Total assets | 12.83B | 7.13% |
Total liabilities | 2.34B | 0.06% |
Total equity | 10.48B | — |
Shares outstanding | 105.02M | — |
Price to book | 1.70 | — |
Return on assets | — | — |
Return on capital | 7.68% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 242.60M | -42.66% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
As of 31 March 2018, its market capitalization is INR 19.20 billion. Wikipedia
Founded
1984
Website
Employees
831
